Change in Preferred Drug List Status for Antihyperuricemics Drug Class On April 22, 2024, the Texas Health and Human Services Commission (HHSC) removed the non-preferred status from products with the brand name Mitigare on the HHSC preferred drug list. Information for drug manufacturers: eCOI Portal training materials available Information for pharmacies: Provider Portal training materials available Pharmacy Education Information and Opportunities Pharmacy Email Addresses Must Be Current in PEMS Information for prescribers: Prescriber Survey Opportunity About Texas Prescription Drug Monitoring Program Ends May 14

---

You have subscribed to get updates about Texas Health and Human Services (HHS). For more information about HHS, please visit our website.

---

Stay Connected
					(en español)

Subscriber Services
Manage Preferences  |  Unsubscribe  |  Help

This email was sent to ooseims.archieves@blogger.com using govDelivery Communications Cloud on behalf of: Texas Health and Human Services Commission · 707 17th St, Suite 4000 · Denver, CO 80202